(redirected from Atypical Ductal Hyperplasia)
Also found in: Dictionary, Medical, Acronyms, Encyclopedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Synonyms for ADH

hormone secreted by the posterior pituitary gland (trade name Pitressin) and also by nerve endings in the hypothalamus

References in periodicals archive ?
All patients with atypical ductal hyperplasia and DCIS were referred to a breast surgeon or oncologist.
19) TABLE 2 Relative risk of developing breast cancer Risk Relative Risk Atypical ductal hyperplasia 4-5 Atypical ductal hyperplasia 6-8 and positive family history TABLE 3 ACS guidelines for screening breast MRI Risk Recommendation <15% lifetime risk MRI not recommended 15% to 20% Talk about benefits and limitations of lifetime risk MRI screening >20% lifetime risk Annual mammogram and annual MRI alternating every 6 months
During the study, researchers examined the rates of atypical ductal hyperplasia to determine risk factors and rates for more than 2.
The risk of developing breast cancer was roughly twice as great 10 years or longer following a benign biopsy featuring atypical ductal hyperplasia as in the first 10 years of follow-up.
Age distributions of patients with carcinoma, atypical ductal hyperplasia (ADH), and atypical lobular hyperplasia (ALH).
Malignant (18%; 31/177) Invasive ductal carcinoma 13 Invasive lobular carcinoma 4 Ductal carcinoma in situ 12 Invasive mixed carcinoma 1 Tubular carcinoma 1 Atypical epithelial hyperplasia (11%; 20/177) Atypical ductal hyperplasia 3 Lobular neoplasia 17 (12 ALH, 5 LCIS) Benign (71%;126/177) Benign breast diagnoses (105/126) Fibrocystic changes with/without 31 epithelial hyperplasia Columnar cell lesions 30 Fibroadenoma and 14 fibroadenomatoid change Ductal ectasia 7 Radial sclerosing lesion 6 Papilloma 7 PASH 5 Intramammary lymph node 3 Fat necrosis 1 Hemangioma 1 Normal breast tissue (21/126) Abbreviations: ALH, atypical lobular hyperplasia; LCIS, lobular carcinoma in situ;PASH, pseudoangiomatous stromal hyperplasia.
1,3) Papillomas may demonstrate a spectrum of atypical features that include atypical ductal hyperplasia (ADH) or low-grade DCIS.
Atypical ductal hyperplasia (ADH), lobular carcinoma in situ (LCIS) and atypical lobular hyperplasia (ALH) may also present with calcifications which may exhibit high density, clustered punctuate calcification and tend to lack the characteristic features of DCIS such as rod shapes, ductal distribution and branching.
Of the total 108 false-positive findings, 39 were diagnosed as atypical ductal hyperplasia.
Investigators classified all benign breast biopsies as either nonproliferative, proliferative without atypia, or atypical hyperplasia, with the atypical hyperplasias being subclassified into atypical lobular hyperplasia or atypical ductal hyperplasia.
Usual ductal hyperplasia (UDH) and atypical ductal hyperplasia (ADH)/low-grade ductal carcinoma in situ (LG-DCIS) are biologically distinct, intraductal, epithelial proliferations with different clinical implications.
7) study, fibrocystic disease was the commonest lesion to be associated with atypical ductal hyperplasia comprising of about 13 cases (30.
Other associated findings included a radial scar, multifocal atypical ductal hyperplasia, and lobular intraeithelial neoplasia.
12 Immunohistochemical (IHC) stains, second review, and changes in processing can be useful, especially in preventing overdiagnosis of atypias, such as atypical ductal hyperplasia (ADH) (ie, false positives).
2% Gynaecomastia, 2% Lactating adenoma, 2% Atypical Ductal Hyperplasia, 1% Duct papilloma and 1% mastitis.
Full browser ?